Literature DB >> 11264182

Human T-cell leukemia virus type I oncoprotein Tax represses Smad-dependent transforming growth factor beta signaling through interaction with CREB-binding protein/p300.

N Mori1, M Morishita, T Tsukazaki, C Z Giam, A Kumatori, Y Tanaka, N Yamamoto.   

Abstract

Human T-cell leukemia virus type I (HTLV-I) Tax is a potent transcriptional regulator that can activate or repress specific cellular genes and that has been proposed to contribute to leukemogenesis in adult T-cell leukemia. Previously, HTLV-I- infected T-cell clones were found to be resistant to growth inhibition by transforming growth factor (TGF)-beta. Here it is shown that Tax can perturb Smad-dependent TGF-beta signaling even though no direct interaction of Tax and Smad proteins could be detected. Importantly, a mutant Tax of CREB-binding protein (CBP)/p300 binding site, could not repress the Smad transactivation function, suggesting that the CBP/p300 binding domain of Tax is essential for the suppression of Smad function. Because both Tax and Smad are known to interact with CBP/p300 for the potentiation of their transcriptional activities, the effect of CBP/p300 on suppression of Smad-mediated transactivation by Tax was examined. Overexpression of CBP/p300 reversed Tax-mediated inhibition of Smad transactivation. Furthermore, Smad could repress Tax transcriptional activation, indicating reciprocal repression between Tax and Smad. These results suggest that Tax interferes with the recruitment of CBP/p300 into transcription initiation complexes on TGF-beta-responsive elements through its binding to CBP/p300. The novel function of Tax as a repressor of TGF-beta signaling may contribute to HTLV-I leukemogenesis. (Blood. 2001;97:2137-2144)

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11264182     DOI: 10.1182/blood.v97.7.2137

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  30 in total

1.  Kaposi's sarcoma-associated herpesvirus-encoded microRNA miR-K12-11 attenuates transforming growth factor beta signaling through suppression of SMAD5.

Authors:  Yunhua Liu; Rui Sun; Xianzhi Lin; Deguang Liang; Qiang Deng; Ke Lan
Journal:  J Virol       Date:  2011-10-19       Impact factor: 5.103

Review 2.  Targeting TGF-β signaling in cancer.

Authors:  Lior H Katz; Ying Li; Jiun-Sheng Chen; Nina M Muñoz; Avijit Majumdar; Jian Chen; Lopa Mishra
Journal:  Expert Opin Ther Targets       Date:  2013-05-07       Impact factor: 6.902

3.  HTLV-1 bZIP factor enhances TGF-β signaling through p300 coactivator.

Authors:  Tiejun Zhao; Yorifumi Satou; Kenji Sugata; Paola Miyazato; Patrick L Green; Takeshi Imamura; Masao Matsuoka
Journal:  Blood       Date:  2011-06-24       Impact factor: 22.113

4.  Persistent inhibition of telomerase reprograms adult T-cell leukemia to p53-dependent senescence.

Authors:  Abhik Datta; Marcia Bellon; Uma Sinha-Datta; Ali Bazarbachi; Yves Lepelletier; Danielle Canioni; Thomas A Waldmann; Olivier Hermine; Christophe Nicot
Journal:  Blood       Date:  2006-03-28       Impact factor: 22.113

Review 5.  Leukemogenesis of adult T-cell leukemia.

Authors:  Jun-ichirou Yasunaga; Masao Matsuoka
Journal:  Int J Hematol       Date:  2003-11       Impact factor: 2.490

Review 6.  T-cell control by human T-cell leukemia/lymphoma virus type 1.

Authors:  Genoveffa Franchini; Risaku Fukumoto; Jake R Fullen
Journal:  Int J Hematol       Date:  2003-11       Impact factor: 2.490

7.  Overexpression of FOXG1 contributes to TGF-beta resistance through inhibition of p21WAF1/CIP1 expression in ovarian cancer.

Authors:  D W Chan; V W S Liu; R M Y To; P M Chiu; W Y W Lee; K M Yao; A N Y Cheung; H Y S Ngan
Journal:  Br J Cancer       Date:  2009-09-15       Impact factor: 7.640

8.  A Kaposi's sarcoma-associated herpesvirus microRNA and its variants target the transforming growth factor β pathway to promote cell survival.

Authors:  Xiufen Lei; Ying Zhu; Tiffany Jones; Zhiqiang Bai; Yufei Huang; Shou-Jiang Gao
Journal:  J Virol       Date:  2012-08-22       Impact factor: 5.103

Review 9.  Role of transforming growth factor-beta in hematologic malignancies.

Authors:  Mei Dong; Gerard C Blobe
Journal:  Blood       Date:  2006-02-16       Impact factor: 22.113

10.  Identification of the minimal melanocyte-specific promoter in the melanocortin receptor 1 gene.

Authors:  Stefania Miccadei; Barbara Pascucci; Mauro Picardo; Pier Giorgio Natali; Donato Civitareale
Journal:  J Exp Clin Cancer Res       Date:  2008-11-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.